NCT00327834已完成4 期
Atomoxetine in the Treatment of Binge Eating Disorder: A Single-Center, Double-Blind, Placebo-Controlled, Flexible Dose Study in Outpatients
Lindner Center of HOPE2 个研究点 分布在 1 个国家开始时间: 2006年5月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 试验地点
- 2
研究概览
简要总结
The specific aim of this study is to assess the efficacy and safety of atomoxetine compared with placebo in outpatients with binge eating disorder.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subjects will meet the DSM-IV criteria for a diagnosis of binge-eating disorder for at least the last 6 months
- •In addition, subjects will report at least 3 binge eating episodes per week for the last 6 months prior to randomization
排除标准
- •Have concurrent symptoms of bulimia nervosa or anorexia nervosa
- •Women who are pregnant, lactating, or of child bearing potential who are not using adequate contraceptive measures
- •Patients who are displaying clinically significant suicidality or homicidality
研究者
研究点 (2)
Loading locations...
相似试验
撤回
3 期
Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late EffectsCognitive Late EffectsCancerNCT00255138Temple University
已完成
2 期
Efficacy and Tolerability of Atomoxetine (Strattera) in Adult Patients With Generalized Social Anxiety DisorderGeneralized Social PhobiaNCT00260533University of California, San Diego27
已完成
3 期
Efficacy Study of Lisdexamfetamine to Treat Binge Eating DisorderBinge Eating DisorderNCT01090713Lindner Center of HOPE50
已完成
不适用
Atomoxetine as an Adjunct to Novel Antipsychotic Medication in the Treatment of Cognitive Deficits of SchizophreniaSchizophreniaNCT00161031University of Maryland, Baltimore30
已完成
4 期
Atomoxetine for Treatment of Weight Gain in Olanzapine or Clozapine PatientsSchizophreniaNCT00176436University of Maryland, Baltimore40